Andrew Skodyn > Blake, Cassels & Graydon LLP > Toronto, Canada > Lawyer Profile

Blake, Cassels & Graydon LLP
199 BAY STREET
SUITE 4000, COMMERCE COURT WEST
TORONTO, ONTARIO M5L 1A9
Canada

Work Department

Litigation & Dispute Resolution

Position

Andrew’s practice is focused on intellectual property and commercial litigation. As an IP litigator, Andrew is best known for his tenacious approach to patent and trademark litigation in the life sciences and information technology areas. His commercial litigation experience spans complex commercial disputes, class actions and product liability defence. Across his diverse litigation practice, Andrew has conducted numerous significant and precedent-setting trials, applications and appeals. He has represented clients in a wide range of industries, from pharmaceuticals and life sciences to information technology, oil and gas, manufacturing, agriculture, banking and professional services. He also has significant experience preparing opinions and advising clients with respect to regulatory issues, intellectual property portfolios and litigation strategy. Andrew has been counsel at all levels of the Ontario and federal courts, including the Supreme Court of Canada, as well as in numerous mediations and arbitrations.

Memberships

Andrew is a regular speaker on intellectual property and advocacy issues, as well as being an active member of numerous professional organizations in Canada and the U.S., including the Intellectual Property Institute of Canada, the Advocates’ Society, the Canadian Bar Association, and the American Bar Association.

Lawyer Rankings

Canada > Intellectual property

Blake, Cassels & Graydon LLP’s team continues to gain ground in the IP space. In particular, it is increasingly active on the contentious front under IP litigation practice head Andrew Skodyn, who frequently leads patent cases for clients such as Janssen and Actelion Pharmaceuticals. Chris Hunter spearheads the overarching IP practice and advises on IP strategy, acquisition, enforcement and exploitation, including patents, trademarks and copyrights; he also acts on the IP aspects of large transactions. Former team co-lead Melanie Baird left the firm in April 2024.